Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15668467 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL
Condition: Lymphoma, Mantle-Cell
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Cisplatinum;   Drug: Ara-C;   Drug: Dexamethasone;   Drug: BCNU;   Drug: Melphalan;   Drug: Etoposide;   Drug: G-CSF;   Procedure: chemotherapy: R-CHOP;   Procedure: chemotherapy: R-DHAP;   Procedure: chemotherapy: Dexa-BEAM;   Procedure: stem cell harvest;   Procedure: total body irradiation;   Procedure: high-dose chemotherapy: Cyclophosphamide;   Procedure: high-dose chemotherapy: Ara-C /Melphalan

Indicates status has not been verified in more than two years